Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25927920 | 0.97 | CHEK2 (0.32) | KDM4EATML3MBTL1LIMK1CHEK2 | |
| SCHEMBL25928019 | 0.97 | CHEK2 (0.32) | KDM4EATML3MBTL1LIMK1CHEK2 | |
| SCHEMBL25927350 | 0.97 | KDM4E (0.31) | KDM4EATML3MBTL1LIMK1PIM3 | |
| SCHEMBL25927236 | 0.97 | KDM4E (0.31) | KDM4EATML3MBTL1LIMK1PIM3 | |
| SCHEMBL25928057 | 0.97 | KDM4E (0.31) | KDM4EATML3MBTL1LIMK1PIM3 | |
| SCHEMBL25928054 | 0.96 | KDM4E (0.33) | KDM4EATML3MBTL1LIMK1PLA2G2A | |
| SCHEMBL25927349 | 0.95 | CHEK2 (0.32) | KDM4EATML3MBTL1LIMK1CHEK2 | |
| SCHEMBL25927234 | 0.95 | CHEK2 (0.32) | KDM4EATML3MBTL1LIMK1CHEK2 | |
| SCHEMBL25927386 | 0.95 | L3MBTL1 (0.34) | KDM4EATML3MBTL1LIMK1PIM3 | |
| SCHEMBL25928062 | 0.95 | L3MBTL1 (0.34) | KDM4EATML3MBTL1LIMK1PIM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-08-03 | — | — | US | disclosed |
| WO-2022025515-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | 엘티소재주식회사 | 2022-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247902-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | KDM4E 2352/4885ATM 2148/4885L3MBTL1 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.